SHG44 were implanted into the frontal lobe of nude mice. After 3 days, tumors were injected with a single dose of recombinant C3 retrovirus or PBS (n = 8/group). Compared with animals treated with PBS (dash line), a significant increase in survival occurs in those treated with recombinant C3 retrovirus (solid line) (p < 0.05).<p><b>Copyright information:</b></p><p>Taken from "Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells and "</p><p>http://www.biomedcentral.com/1471-2407/8/29</p><p>BMC Cancer 2008;8():29-29.</p><p>Published online 29 Jan 2008</p><p>PMCID:PMC2270850.</p><p></p
